Micro Doses, Macro Potential? Considerations for Microdosing Tirzepatide in Multi‐Dose Pens

Obesity 2026 Open access

Read full text
Authors: Abigail B. Lodrigues, Alissa V. Russell, Shelby Tungate Lopez, Anne M. Komé
DOI: 10.1002/oby.70253
Cited by: 1
References: 6

Abstract

A.M.K. has received advisory/consulting fees from Camurus Pharmaceuticals, Dexcom Inc., Eli Lilly and Company, and Lexidrug/Wolters-Kluwer. A.B.L., A.V.R., and S.T.L. declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Fields of Study & Subjects

Carcinogens and Genotoxicity Assessment Pharmacogenetics and Drug Metabolism Radiation Dose and Imaging

Publication details

Journal / source
Obesity
Publisher
Wiley
Volume
34
Issue
9
Pages
1684–1686
Publication date
4 June 2026
Language
EN